Juluca 50-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8F4B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,007
Award facts
- Contract value 100% obligated
- $20,006.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $20,006.90 delivery order to Amerisourcebergen Drug Corp on March 16, 2026, for JULUCA 50–25 mg tablets (30-count units).
The order is issued under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and running through December 2026. The order uses firm fixed pricing with no set-aside. Place of performance is Conshohocken, PA. Ultimate completion date is March 17, 2026.
Quick answers
Who was awarded contract SPE2DR26F8F4B?
SPE2DR26F8F4B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 16, 2026.
How much is contract SPE2DR26F8F4B worth?
The government has obligated $20,007 on SPE2DR26F8F4B.
Is contract SPE2DR26F8F4B an order under another contract?
Yes. SPE2DR26F8F4B is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8F4B competed?
The extent of competition for SPE2DR26F8F4B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award